Amplia Therapeutics (ATX) Short Interest
Amplia Therapeutics (ASX:ATX) had 0.01% of shares reported as short positions as of 24 Aug 2026, representing 30,144 shares. Amplia Therapeutics operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Amplia Therapeutics
Amplia Therapeutics Limited focuses on developing therapies targeting focal adhesion kinase (FAK) inhibitors for the treatment of cancer and fibrosis. The company is positioned within the biotechnology sector, leveraging advanced scientific research to develop clinical candidates aimed at unmet medical needs, potentially offering transformative therapies in oncology and fibrotic diseases.
Short position
Amplia Therapeutics (ASX:ATX) has 0.01% of its shares on issue reported as short positions as of 24 Aug 2026, or about 30,144 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.15% in November 2024. ATX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ATX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Amplia Therapeutics
Latest ATX news
All news- Results of Annual General Meeting
asx
- CEO Managing Director Presentation to Annual General Meeting
asx
- Amplia Therapeutics Limited (ASX:ATX) Share Price Rises 3.57% as Stock Trades Near Session High - Kalkine
googlenews
- Amplia Therapeutics Ltd (ASX: ATX) Share Price Update: Trading Activity and Biotechnology Sector Trends on August 7, 2026 - Kalkine
googlenews
- Bioshares Biotech Summit Presentation
asx
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ATX
Start a research thread or post the first pulse update